ARTICLE | Clinical News
Avant reports Phase IIb cholera data
May 8, 2001 7:00 AM UTC
AVAN said that in a double-blind Phase IIb study of its Peru-15 oral cholera vaccine in 59 healthy volunteers, the product gave 100% protection against moderate and severe diarrhea following challenge...